Immunoglobulin deposits in leprosy skin

Area of Science:

• Immunology
• Dermatology
• Rheumatology

Background:

• Leprosy is a chronic infectious disease affecting the skin and peripheral nerves.
• Treatment for leprosy often involves multidrug therapy, including dapsone and clofazimine.
• Immune system dysregulation and autoantibody production may play a role in leprosy pathogenesis.

Purpose of the Study:

• To investigate immunoglobulin (Ig) and complement deposits in skin biopsies of leprosy patients.
• To assess the presence of autoantibodies and rheumatoid factor in leprosy patients.
• To explore the potential role of autoantibodies in the immunopathology of leprosy.

Main Methods:

• Immunofluorescence studies were performed on skin biopsies from 12 leprosy patients.
• Serum immunoglobulin levels, rheumatoid factor, anti-epithelial antibodies, and anti-nuclear antibodies were measured.
• Patients had a history of dapsone and clofazimine treatment.

Main Results:

• All 12 patients exhibited IgG deposits at the dermal-epidermal junction.
• Seven of the 12 patients showed IgM deposits at the dermal-epidermal junction.
• Elevated serum immunoglobulin levels, rheumatoid factor, anti-epithelial antibodies (8/12), and anti-nuclear antibodies (3/12) were observed.

Conclusions:

• Leprosy patients, even after treatment, can display significant immunoglobulin deposits in the skin.
• The presence of autoantibodies and rheumatoid factor suggests an autoimmune component in some leprosy patients.
• Further research is warranted to elucidate the specific role of autoantibodies in leprosy and its complications.